Fulcrum Therapeutics
The Director of Biostatistics at Fulcrum Therapeutics leads statistical activities for clinical development programs, ensuring regulatory compliance and methodological innovation. The role requires expertise in study design, statistical analysis, and collaboration across departments.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Fulcrum Therapeutics is a clinical‑stage biotechnology company that discovers and develops small molecules to modulate gene expression and address the root causes of genetically defined diseases. Their approach focuses on transcriptional regulation and restoring healthy gene programs through genetics‑driven target identification and proprietary discovery platforms. Fulcrum advances a pipeline of precision medicines across genetically defined indications while emphasizing translational science, patient impact, and a collaborative organizational culture.
Fulcrum Therapeutics, Inc. $FULC Shares Bought by Boothbay Fund Management LLC
15 hours ago
Boothbay Fund Management Increases Stake in Fulcrum Therapeutics
14 hours ago
Wall Street analysts think Fulcrum Therapeutics (FULC) could surge 58.47%: Read this before placing a bet
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fulcrum Therapeutics.
14% above the average for this role
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
3 weeks ago